Document Detail

Somatostatin analog (octreotide) in management of neonatal postoperative chylothorax: is it safe?
MedLine Citation:
PMID:  15215005     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: Somatostatin and its analogs have recently been introduced in the treatment of chylous effusions in infants and children following surgery. The safety profile of this treatment in critically ill patients has not been fully evaluated. DESIGN: Retrospective case review. SETTING: Tertiary pediatric cardiac center. PATIENTS: A male infant born by cesarean section with a birth weight of 2.6 kg. INTERVENTIONS: None. CONCLUSIONS: We report the association of postoperative chylothorax treated with somatostatin analog (octreotide) and necrotizing enterocolitis in an infant following aortic coarctation repair.
Hadi Mohseni-Bod; Duncan Macrae; Zdenek Slavik
Related Documents :
24010115 - Clinical factors affecting lipid metabolism and optimal dose of heparin in preterm infa...
15467565 - Maternal outcomes at 2 years after planned cesarean section versus planned vaginal birt...
2360575 - A comparison of the morbidity of midforceps and cesarean delivery.
3807975 - Comparisons of national cesarean-section rates.
3868885 - Preferential looking grating acuities of infants at risk of amblyopia.
25322995 - Variation and comparative effectiveness of patent ductus arteriosus pharmacotherapy in ...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies     Volume:  5     ISSN:  1529-7535     ISO Abbreviation:  Pediatr Crit Care Med     Publication Date:  2004 Jul 
Date Detail:
Created Date:  2004-06-24     Completed Date:  2004-10-07     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  100954653     Medline TA:  Pediatr Crit Care Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  356-7     Citation Subset:  IM    
Paediatric Intensive Care Unit, Royal Brompton & Harefield NHS Trust, Royal Brompton Hospital, London, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aortic Coarctation / surgery
Cardiac Surgical Procedures / adverse effects*
Chylothorax / drug therapy*,  etiology
Gastrointestinal Agents / therapeutic use*
Infant, Newborn
Octreotide / therapeutic use*
Postoperative Complications / drug therapy*
Reg. No./Substance:
0/Gastrointestinal Agents; 83150-76-9/Octreotide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Factors contributing to successful discontinuation from inhaled nitric oxide therapy in pediatric pa...
Next Document:  Identifying children at high risk for psychological sequelae after pediatric intensive care unit hos...